Our Commitment to Equity
Equity is critical to the health and well-being of black and brown communities, and remains essential to a robust ecosystem of innovation. America’s biopharmaceutical companies are pushing for necessary systemic and long-term change to better meet the needs of Black and Brown America.

That means:
- Open, honest, real conversations about racial equity and what it means to have a culture of inclusion.
- Expanding opportunities to work and succeed in our industry.
- Advancing policy solutions and research to better address health disparities.
- Diversifying our business practices to better invest in Black and Brown America.
- Earning trust and addressing systemic issues that deter Black and Brown communities from participating in clinical trials, so that people who want to participate, can.